{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:38:15Z","timestamp":1789256295654,"version":"build-2803163510"},"reference-count":36,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: The prognostic value of the comprehensive geriatric assessment (CGA) is recognized by many in hematology. However, there is no consensus on the utilization of alternative abbreviated methods to assess disabilities in elderly patients with B-cell non-Hodgkin\u2019s lymphomas (B-NHLs). Aim: The aim of this study was to prospectively analyze the prognostic value of selected CGA tools in predicting adverse events (AEs) and outcomes of R-CHOP or R-CHOP-like treatment in elderly patients with diffuse large B-cell lymphomas (DLBCLs) or mantle cell lymphomas (MCLs). Methods: All patients who participated in this study underwent the Katz Index of Independence in Activities of Daily Living (ADL), the Lawton Instrumental Activities of Daily Living (iADL) scale, the Vulnerable Elders Survey-13 (VES-13), the Groningen Frailty Index (GFI), and the Mini Nutritional Assessment Short Form (MNA-SF) before starting anticancer treatment. Selected clinical predictors were also included in the study. Results: A total of 62 patients with newly diagnosed DLBCLs or MCLs, treated with R-CHOP in the Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation of Wroclaw University Hospital between 1 July 2018, and 1 July 2020, were included in the study. The median age upon initiation of the treatment was 72 years (range: 61\u201368). Multinomial logistic regression and Cox proportional hazard regression analysis demonstrated that the iADL scale was significantly associated with response to treatment (OR = 1.21, 95% CI: 1.02\u20131.44, p = 0.03), was inversely related to non-hematological AEs (OR = 0.81, 95% CI: 0.71\u20130.92, p = 0.001), and was a statistically significant predictor of longer overall survival (OS) (HR = 0.83, 95% CI: 0.79\u20130.89, p &lt; 0.001) and longer progression-free survival (PFS) (HR = 0.91, 95% CI: 0.83\u20130.99, p = 0.03). Conclusions: These results underscore the effectiveness of the iADL scale as a quick, easy-to-use, and universal CGA tool for evaluating crucial functional status before treatment in elderly hematological patients with DLBCLs or MCLs.<\/jats:p>","DOI":"10.3390\/cancers16244170","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:08:53Z","timestamp":1734343733000},"page":"4170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of the Lawton Instrumental Activities of Daily Living (IADL) Scale in Predicting Adverse Events and Outcomes of R-CHOP Treatment in Elderly Patients with Diffuse Large B-Cell Lymphomas (DLBCLs) or Mantle Cell Lymphomas (MCLs): A Prospective Single-Center Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-2116","authenticated-orcid":false,"given":"Paula","family":"Jab\u0142onowska-Babij","sequence":"first","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Olszewska-Szopa","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"Potoczek","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-296X","authenticated-orcid":false,"given":"Maciej","family":"Majcherek","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-3180","authenticated-orcid":false,"given":"Agnieszka","family":"Szeremet","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-4702","authenticated-orcid":false,"given":"Krzysztof","family":"Kujawa","sequence":"additional","affiliation":[{"name":"Statistical Analysis Centre, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-0182","authenticated-orcid":false,"given":"Anna","family":"Czy\u017c","sequence":"additional","affiliation":[{"name":"Clinical Department of Hematology, Cell Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Thandra, K.C., Barsouk, A., Saginala, K., Padala, S.A., Barsouk, A., and Rawla, P. (2021). Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med. Sci., 9.","DOI":"10.3390\/medsci9010005"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12032-013-0708-3","article-title":"The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer","volume":"30","author":"Castagneto","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.sger.2019.03.010","article-title":"Essais cliniques et personnes \u00e2g\u00e9es canc\u00e9reuses, l\u2019outil Geriatric Core Dataset (G-Code) [Clinical trials and elderly patients with cancer, the Geriatric Core Dataset (G-Code) tool]","volume":"24","author":"Paillaud","year":"2019","journal-title":"Soins Gerontol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"afab282","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5045\/br.2022.2021218","article-title":"Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy","volume":"57","author":"Choi","year":"2022","journal-title":"Blood Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ageing\/afx166","article-title":"What is Comprehensive Geriatric Assessment (CGA)? An umbrella review","volume":"47","author":"Parker","year":"2018","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jgo.2022.02.013","article-title":"G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer","volume":"13","author":"Shah","year":"2022","journal-title":"J. Geriatr. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/jnr.0000000000000299","article-title":"Frail Phenotype and Disability Prediction in Community-Dwelling Older People: A Systematic Review and Meta-Analysis of Prospective Cohort Studies","volume":"27","author":"Chang","year":"2019","journal-title":"J. Nurs. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1634\/theoncologist.2012-0186","article-title":"The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer","volume":"17","author":"Hamaker","year":"2012","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41256-023-00323-0","article-title":"Geriatric assessment for older people with cancer: Policy recommendations","volume":"8","author":"Seghers","year":"2023","journal-title":"Glob. Health Res. Policy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgo.2016.02.007","article-title":"Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research","volume":"7","author":"Magnuson","year":"2016","journal-title":"J. Geriatr. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.22.01007","article-title":"Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults with Cancer: The Randomized 5C Trial","volume":"41","author":"Puts","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_13","first-page":"33","article-title":"Assessment tools to evaluate Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) in older adults: A systematic review","volume":"34","author":"Pashmdarfard","year":"2020","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111151","DOI":"10.1016\/j.jclinane.2023.111151","article-title":"Incidence of preoperative instrumental activities of daily living (IADL) dependence and adverse outcomes in older surgical patients: A systematic review and meta-analysis","volume":"89","author":"Chen","year":"2023","journal-title":"J. Clin. Anesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.NAJ.0000314810.46029.74","article-title":"The Lawton instrumental activities of daily living scale","volume":"108","author":"Graf","year":"2008","journal-title":"Am. J. Nurs."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s00277-021-04592-y","article-title":"Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma","volume":"100","author":"Nakazato","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e42017","DOI":"10.2196\/42017","article-title":"Assessment of Frailty by the French Version of the Vulnerable Elders Survey-13 on Digital Tablet: Validation Study","volume":"25","author":"Pariel","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Drubbel, I., Bleijenberg, N., Kranenburg, G., Eijkemans, R.J., Schuurmans, M.J., de Wit, N.J., and Numans, M.E. (2013). Identifying frailty: Do the Frailty Index and Groningen Frailty Indicator cover different clinical perspectives? a cross-sectional study. BMC Fam. Pract., 14.","DOI":"10.1186\/1471-2296-14-64"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10433-019-00502-4","article-title":"The ability of four frailty screening instruments to predict mortality, hospitalization and dependency in (instrumental) activities of daily living","volume":"16","author":"Beurskens","year":"2019","journal-title":"Eur. J. Ageing"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Holvoet, E., Vanden Wyngaert, K., Van Craenenbroeck, A.H., Van Biesen, W., and Eloot, S. (2020). The screening score of Mini Nutritional Assessment (MNA) is a useful routine screening tool for malnutrition risk in patients on maintenance dialysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229722"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2018.02.005","article-title":"A review of the validity of malnutrition screening tools used in older adults in community and healthcare settings\u2014A MaNuEL study","volume":"24","author":"Power","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.tjnut.2024.05.010","article-title":"Comparison of Mini Nutritional Assessment Tool and Geriatric Nutrition Risk Index in Predicting 12-Y Mortality Among Community-Dwelling Older Persons","volume":"154","author":"Li","year":"2024","journal-title":"J. Nutr."},{"key":"ref_23","unstructured":"(2024, July 02). NCCN Guidelines. Available online: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1480."},{"key":"ref_24","unstructured":"(2024, July 02). ESMO Guidelines. Available online: https:\/\/www.esmo.org\/guidelines\/guidelines-by-topic\/esmo-clinical-practice-guidelines-haematological-malignancies."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1182\/blood-2022-159417","article-title":"Comprehensive Geriatric Assessment Is a Useful Tool for Predicting the Outcome of Elderly Patients with Hematologic Malignancies in Real Life","volume":"140","author":"Landete","year":"2022","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/ejh.13570","article-title":"Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies","volume":"106","author":"Garric","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10354-021-00905-y","article-title":"Comprehensive geriatric assessment","volume":"172","author":"Schippinger","year":"2022","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Doi, A., Mizukami, T., Takeda, H., Umemoto, K., Arai, H., Horie, Y., Izawa, N., Ogura, T., and Sunakawa, Y. (2023). Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1110236"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.clml.2015.03.004","article-title":"Prognostic effect of comorbidity indices in elderly patients with multiple myeloma","volume":"15","author":"Bila","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1634\/theoncologist.2017-0361","article-title":"Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment","volume":"23","author":"Liu","year":"2018","journal-title":"Oncologist"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00432-006-0115-7","article-title":"Impairment in functional status and survival in patients with acute myeloid leukaemia","volume":"132","author":"Wedding","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/10428194.2015.1091933","article-title":"Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group","volume":"57","author":"Goede","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.revmed.2007.12.015","article-title":"H\u00e9mopathies et sujets \u00e2g\u00e9s: Exp\u00e9rience d\u2019un service de court s\u00e9jour g\u00e9riatrique [Haematological malignancies in older adults: Experience in a geriatric acute care department]","volume":"29","author":"Lahjibi","year":"2008","journal-title":"Rev. Med. Interne"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jgo.2018.04.001","article-title":"Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review","volume":"10","author":"Hoeben","year":"2019","journal-title":"J. Geriatr. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.2013.51.1345","article-title":"Performance of two geriatric screening tools in older patients with cancer","volume":"32","author":"Kenis","year":"2014","journal-title":"J. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/24\/4170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:20Z","timestamp":1760115320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/24\/4170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":36,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cancers16244170"],"URL":"https:\/\/doi.org\/10.3390\/cancers16244170","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]}}}